Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
Maqola

Neuroimmune Cross‐Talk and Multilevel Cascades in Fentanyl Toxicity: Interplay of Hypoxic Stress, Glial Activation, and Synaptic Dysregulation in Systems‐Level Neurodegeneration

Hamzeh J. Al‐AmeerFaculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research Al‐Ahliyya Amman University Amman JordanNoor Mazin BasheerDepartment of Medical Laboratory Technics, College of Health and Medical Technology Alnoor University mosul IraqH MalathiDepartment of Biotechnology and Genetics, School of Sciences JAIN (Deemed to be University) Bangalore Karnataka IndiaAman ShankhyanCentre for Research Impact & Outcome, Chitkara University Institute of Engineering and Technology Chitkara University Rajpura Punjab IndiaRajashree PanigrahiDepartment of Microbiology IMS and SUM Hospital, Siksha 'O' Anusandhan Bhubaneswar Odisha IndiaVimal AroraUniversity Institute of Pharma Sciences Chandigarh University Mohali Punjab IndiaKhushnud AzizjanovDepartment of Natural Sciences Ma'mun University Khiva UzbekistanErkabay EshchanovDepartment of Chemistry Urgench State University Urgench UzbekistanZokir AtaullaevNatural Science Department Urganch State Pedagogical Institute Urgench Uzbekistan
ABI

Annotatsiya

Fentanyl, an ultra-potent synthetic opioid, has traditionally been characterized by its acute toxic effects, particularly respiratory depression. However, accumulating research indicates that its neurobiological influence extends far beyond its short pharmacological window, intersecting with several core mechanisms implicated in major neurodegenerative disorders. This review integrates multiscale evidence to propose a unified conceptual framework in which fentanyl may function not only as an acute neurotoxin but also as a putative accelerator of long-term neurodegenerative vulnerability. Drawing from molecular signaling, cellular stress pathways, glial-neuronal cross-talk, neurovascular regulation, synaptic architecture, and large-scale neural networks, we highlight fentanyl's capacity to trigger a convergent cascade encompassing hypoxic-metabolic reprogramming, mitochondrial fragmentation, TLR4-NF-κB-driven inflammation, NLRP3 inflammasome activation, complement-mediated synaptic pruning, astrocytic EAAT2 downregulation, and blood-brain barrier compromise. These alterations propagate through recursive cross-talk loops that progressively diminish neuronal resilience, destabilize oscillatory coherence, and weaken circuit-level adaptability. Importantly, mechanistic overlaps with Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis suggest that fentanyl exposure may be mechanistically associated with processes capable of accelerating disease onset, exacerbating progression, or unmasking latent vulnerabilities, particularly in genetically or metabolically predisposed individuals. By reframing fentanyl as a systems-level destabilizer capable of imprinting persistent neurobiological changes, this model underscores the need for comprehensive biomarker development, longitudinal risk assessment, and targeted neuroprotective interventions. The integrative framework presented herein offers a foundation for predicting the long-term neurological consequences of fentanyl exposure and calls for urgent reconsideration of its role in population-level neurodegenerative risk.

Hali tarjima qilinmagan

Mavzular

Identifikatorlar

Iqtiboslar va manbalar